The opportunity within the Fill Finish Manufacturing of Biologics Market to grow at ~10% CAGR till 2035, according to a market research report by Roots Analysis
Comunicato Precedente
Comunicato Successivo
The biopharmaceutical industry has witnessed substantial number of partnerships and collaborations between drug developers and fill/finish contract manufacturing organizations over the last few years. The COVID 19 pandemic also led to an increase in the demand for fill finish of vaccines, leading to a rise in the number of service agreements. For fulfilling the demand for its COVID vaccine in Europe, Pfizer and BioNTech collaborated with Delpharm, Thermo Fisher Scientific and more companies for fill&finish operations. Similarly, Moderna entered into service agreements with Catalent, ROVI, Thermo Fisher, Recipharm, Samsung Biologics and other companies to fulfill the fill&finish demand for its COVID vaccine. We believe that service providers are likely to continue undertaking similar initiatives in the short-term to consolidate their presence in this field, distinguish themselves from the competition and cater to the diversified needs of their clientele.
To order this 550+ page report, which features 280+ figures and 230+ tables, please visit https://www.rootsanalysis.com/reports/biologics-fill-finish-services-market/256.html
Key Market Insights
For additional details, please visit https://www.rootsanalysis.com/reports/biologics-fill-finish-services-market/256.html
The financial opportunity within the biologics fill / finish services market has been analyzed across the following segments:
The report features inputs from eminent industry stakeholders, according to whom, a significant increase in the demand for cell and gene therapies is driving the growth of the biologics fill / finish market. The report includes detailed transcripts of discussions held with the following experts:
The research also includes detailed profiles of key players (listed below) engaged in offering biologics fill / finish services; each profile features a brief overview of the company, its financial information (if available), details on biologics fill / finish services, location of facilities recent developments and an informed future outlook.
Key Questions Answered
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Biologics Fill / Finish Service Providers: Market Landscape
5. Company Competitiveness Analysis
6. Biologics Fill / Finish Service Providers in North America
7. Biologics Fill / Finish Service Providers in Europe
8. Biologics Fill / Finish Service Providers in Asia-Pacific
9. Recent Partnerships
10. Recent Expansions
11. Capacity Analysis
12. Demand Analysis
13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish
14. Regional Capability Assessment
15. Market Sizing and Opportunity Analysis
16. Future Growth Opportunities
17. Case Study: Robotic Systems in Fill / Finish Operations
18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish
19. Concluding Remarks
20. Executive Insights
21. Appendix 1: Tabulated Data
22. Appendix 2: List of Companies and Organizations
For additional details, please visit https://www.rootsanalysis.com/reports/biologics-fill-finish-services-market/256.html or email sales@rootsanalysis.com
You may also be interested in the following titles:
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
gaurav.chaudhary@rootsanalysis.com
Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/the-opportunity-within-the-fill-finish-manufacturing-of-biologics-market-to-grow-at-10-cagr-till-2035-according-to-a-market-research-report-by-roots-analysis-301925007.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
